Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
Tiago Azenha Rama, André Moreira, Mariana Castells
J Allergy Clin Immunol. 2021 Mar; 147(3): 877–878. Published online 2021 Jan 19. doi: 10.1016/j.jaci.2021.01.004
PMCID:
PMC7816615
Article PDF–156K

Is Cited by the Following 24 Articles in this Archive:

Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis
Matthew P. Giannetti, Jennifer Nicoloro-SantaBarbara, Grace Godwin, Julia Middlesworth, Andrew Espeland, Julia L. Douvas, Mariana C. Castells
Diagnostics (Basel) 2024 Jan; 14(2): 123. Published online 2024 Jan 5. doi: 10.3390/diagnostics14020123
PMCID:
PMC10814166
Article PDF–286K
The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis
Muhammad Bilal Khalid, Pamela A. Frischmeyer-Guerrerio
J Allergy Clin Immunol Glob. 2023 Feb; 2(1): 1–13. Published online 2022 Dec 13. doi: 10.1016/j.jacig.2022.10.003
PMCID:
PMC9746073
Article PDF–1.5M
Treatment of Advanced Systemic Mastocytosis with Midostaurin: Practical Guidance for Optimal Therapy and Management
Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni
Mediterr J Hematol Infect Dis. 2022; 14(1): e2022073. Published online 2022 Nov 1. doi: 10.4084/MJHID.2022.073
PMCID:
PMC9652003
Article PDF–452K
Outcomes of COVID‐19 vaccination in 323 patients with clonal and non‐clonal mast cell activation disorders
Matthew P. Giannetti, Francesco Olivieri, Grace Godwin, Emma Weller, Jennifer Nicoloro‐SantaBarbara, Patrizia Bonadonna, Roberta Zanotti, Giovanna Zanoni, Karin Hartmann, Mariana Castells
Allergy. 2022 Aug 23 : 10.1111/all.15476. doi: 10.1111/all.15476 [Epub ahead of print]
PMCID:
PMC9538600
Article PDF–382K
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication
Tiago Azenha Rama, Joana Miranda, Diana Silva, Luís Amaral, Eunice Castro, Alice Coimbra, André Moreira, José Luís Plácido
Vaccines (Basel) 2022 May; 10(5): 718. Published online 2022 May 4. doi: 10.3390/vaccines10050718
PMCID:
PMC9146268
Article PDF–349K
SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
Gülseren Tuncay, Ozge Can Bostan, Ebru Damadoglu, Gül Karakaya, Ali Fuat Kalyoncu
Ann Allergy Asthma Immunol. 2022 Jun; 128(6): 733–734. Published online 2022 Mar 4. doi: 10.1016/j.anai.2022.02.026
PMCID:
PMC8894735
Article PDF–192K
Graded coronavirus disease 2019 vaccine administration: A safe alternative to vaccine avoidance
Mitchell M. Pitlick, Alexei Gonzalez-Estrada, Miguel A. Park
Ann Allergy Asthma Immunol. 2022 Jun; 128(6): 731–733. Published online 2022 Mar 4. doi: 10.1016/j.anai.2022.02.024
PMCID:
PMC8894737
Article PDF–193K
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
Toon Ieven, Martijn Vandebotermet, Lisa Nuyttens, David Devolder, Peter Vandenberghe, Dominique Bullens, Rik Schrijvers
Vaccines (Basel) 2022 Feb; 10(2): 286. Published online 2022 Feb 14. doi: 10.3390/vaccines10020286
PMCID:
PMC8879861
Article PDF–737K
A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor
László Dézsi, Tamás Mészáros, Gergely Kozma, Mária H-Velkei, Csaba Zs. Oláh, Miklós Szabó, Zsófia Patkó, Tamás Fülöp, Mark Hennies, Miklós Szebeni, Bálint András Barta, Béla Merkely, Tamás Radovits, János Szebeni
GeroScience. 2022 Apr; 44(2): 597–618. Published online 2022 Feb 11. doi: 10.1007/s11357-021-00495-y
PMCID:
PMC8831099
Article PDF–2.5M
Evaluation of the Autoimmunity and Preexisting Risky Conditions for Hypersensitivity Reactions to COVID-19 Vaccines
Can Tuzer, Kadriye Terzioglu
Int Arch Allergy Immunol. 2022 Feb 3 : 1–11. Published online 2022 Feb 3. doi: 10.1159/000521709
PMCID:
PMC9059002
Article PDF–479K
Safety of COVID-19 vaccination in patients with clonal mast cell disorders
Maria Ruano-Zaragoza, Laura V. Carpio-Escalona, Marina Diaz-Beya, Miguel Piris-Villaespesa, Sandra Castaño-Diez, Rosa Muñoz-Cano, David González-de-Olano
J Allergy Clin Immunol Pract. 2022 May; 10(5): 1374–1376.e3. Published online 2022 Feb 1. doi: 10.1016/j.jaip.2022.01.030
PMCID:
PMC8806141
Article PDF–245K
Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
Amer Al-Musa, Brenna LaBere, Saddiq Habiballah, Alan A. Nguyen, Janet Chou
J Allergy Clin Immunol. 2022 Feb; 149(2): 569–578. Published online 2021 Dec 24. doi: 10.1016/j.jaci.2021.12.775
PMCID:
PMC8704728
Article PDF–618K
L'anaphylaxie et les vaccins COVID-19
M. Castells, P. Demoly, L.K. Tanno
Rev Fr Allergol (2009) 2021 Dec; 61(8): 8S30–8S35. French. Publication en ligne 2021 déc. 30. DOI : 10.1016/S1877-0320(21)00439-5
PMCID:
PMC8716577
Article PDF–1.8M
A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination
Priya Sriskandarajah, Jess Hobart, Deepti H. Radia, Andrew F. Whyte
Hemasphere. 2021 Nov; 5(11): e650. Published online 2021 Oct 15. doi: 10.1097/HS9.0000000000000650
PMCID:
PMC8517291
Article PDF–598K
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases
Giuseppe A. Ramirez, Chiara Asperti, Valentina Cucca, Mona-Rita Yacoub
Vaccines (Basel) 2021 Oct; 9(10): 1147. Published online 2021 Oct 8. doi: 10.3390/vaccines9101147
PMCID:
PMC8537812
Article PDF–385K
COVID-19 Vaccines in Children with Cow’s Milk and Food Allergies
Lucia Liotti, Annamaria Bianchi, Paolo Bottau, Silvia Caimmi, Giuseppe Crisafulli, Fabrizio Franceschini, Francesca Mori, Claudia Paglialunga, Francesca Saretta, Carlo Caffarelli
Nutrients. 2021 Aug; 13(8): 2637. Published online 2021 Jul 30. doi: 10.3390/nu13082637
PMCID:
PMC8401713
Article PDF–536K
COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group
Mi-Ae Kim, Yong Won Lee, So Ri Kim, Joo-Hee Kim, Taek ki Min, Hae-Sim Park, Meeyong Shin, Young-Min Ye, Sooyoung Lee, Jeongmin Lee, Jeong-Hee Choi, Gwang Cheon Jang, Yoon-Seok Chang
Allergy Asthma Immunol Res. 2021 Jul; 13(4): 526–544. Published online 2021 Jun 21. doi: 10.4168/aair.2021.13.4.526
PMCID:
PMC8255352
Article PDF–2.0M
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
Rayan Kaakati, Dilawar Khokhar, Cem Akin
J Allergy Clin Immunol Pract. 2021 Aug; 9(8): 3198–3199. Published online 2021 May 24. doi: 10.1016/j.jaip.2021.05.010
PMCID:
PMC8141687
Article PDF–236K
Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe: Ein Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA), der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) und der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)
Ludger Klimek, Karl-Christian Bergmann, Randolf Brehler, Wolfgang Pfützner, Margitta Worm, Karin Hartmann, Thilo Jakob, Natalija Novak, Johannes Ring, Eckard Hamelmann, Tobias Ankermann, Sebastian M. Schmidt, Eva Untersmayr, Wolfram Hötzenecker, Erika Jensen-Jarolim, Torsten Zuberbier
Allergo J. 2021; 30(3): 22–43. German. Published online 2021 May 7. doi: 10.1007/s15007-021-4773-1
PMCID:
PMC8091634
Article PDF–2.2M
New Insights into the Pathogenesis of Systemic Mastocytosis
Zhixiong Li
Int J Mol Sci. 2021 May; 22(9): 4900. Published online 2021 May 5. doi: 10.3390/ijms22094900
PMCID:
PMC8125314
Article PDF–874K
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
Kimberly A. Risma, Kathryn M. Edwards, Donna S. Hummell, Frederic F. Little, Allison E. Norton, Amy Stallings, Robert A. Wood, Joshua D. Milner
J Allergy Clin Immunol. 2021 Jun; 147(6): 2075–2082.e2. Published online 2021 Apr 20. doi: 10.1016/j.jaci.2021.04.002
PMCID:
PMC8056854
Article PDF–1.6M
Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
Ludger Klimek, Karl-Christian Bergmann, Randolf Brehler, Wolfgang Pfützner, Torsten Zuberbier, Karin Hartmann, Thilo Jakob, Natalija Novak, Johannes Ring, Hans Merk, Eckard Hamelmann, Tobias Ankermann, Sebastian Schmidt, Eva Untersmayr, Wolfram Hötzenecker, Erika Jensen-Jarolim, Knut Brockow, Vera Mahler, Margitta Worm
Allergo J Int. 2021; 30(3): 79–95. Published online 2021 Apr 19. doi: 10.1007/s40629-021-00165-7
PMCID:
PMC8054127
Article PDF–712K
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital
Giovanni Paoletti, Francesca Racca, Alessandra Piona, Giulio Melone, Morena Merigo, Francesca Puggioni, Sebastian Ferri, Elena Azzolini, Michele Lagioia, Donatella Lamacchia, Giuseppe Cataldo, Maurizio Cecconi, Giorgio Walter Canonica, Enrico Heffler
World Allergy Organ J. 2021 May; 14(5): 100541. Published online 2021 Apr 8. doi: 10.1016/j.waojou.2021.100541
PMCID:
PMC8030995
Article PDF–686K
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, Hanneke Oude Elberink, Cem Akin, Boguslaw Nedoszytko, Joseph H. Butterfield, Ivan Alvarez-Twose, Karl Sotlar, Juliana Schwaab, Mohamad Jawhar, Mariana Castells, Wolfgang R. Sperr, Olivier Hermine, Jason Gotlib, Roberta Zanotti, Andreas Reiter, Sigurd Broesby-Olsen, Carsten Bindslev-Jensen, Lawrence B. Schwartz, Hans-Peter Horny, Deepti Radia, Massimo Triggiani, Vito Sabato, Melody C. Carter, Frank Siebenhaar, Alberto Orfao, Clive Grattan, Dean D. Metcalfe, Michel Arock, Theo Gulen, Karin Hartmann, Peter Valent
J Allergy Clin Immunol Pract. 2021 Jun; 9(6): 2139–2144. Published online 2021 Apr 5. doi: 10.1016/j.jaip.2021.03.041
PMCID:
PMC8019658
Article PDF–427K